|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| C07D 405/14 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/4525 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/4525 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 16/2827 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| C07K2317/73 | (2013.01) |
| (11) | Patento numeris | 3551629 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17879038.2 |
| Europos patento paraiškos padavimo data | 2017-12-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/065270 |
| Data | 2017-12-08 |
| (87) | Numeris | WO 2018/107004 |
| Data | 2018-06-14 |
| (30) | Numeris | Data | Šalis |
| 201662497949 P | 2016-12-08 | US | |
| 201762465001 P | 2017-02-28 | US | |
| 201762545373 P | 2017-08-14 | US |
| (72) |
KOVACH, John S. , US
ZHUANG, Zhengping , US
HO, Sze Chun Winson , US
WANG, Herui , US
LU, Rongze , US
|
| (73) |
Lixte Biotechnology, Inc. ,
680 E. Colorado Blvd., Suite 180, Pasadena, CA 91101,
US
The U.S.A. as represented by the Secretary, Department of Health and Human Services , Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive, Suite 700, Bethesda, MD 20892, US |
| (54) | OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE |
| OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE |